Tang Haiting, Wei Wei, Luo Yu, Lu Xiaoqing, Chen Jun, Yang Shenqiao, Wu Fei, Zhou Haiyan, Ma Wenbin, Yang Xin
School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
School of Foreign Languages, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Purinergic Signal. 2024 Feb 29. doi: 10.1007/s11302-024-09996-9.
For many years, there has been ongoing research on the P2X7 receptor (P2X7R). A comprehensive, systematic, and objective evaluation of the scientific output and status of P2X7R will be instrumental in guiding future research directions. This study aims to present the status and trends of P2X7R research from 2002 to 2023. Publications related to P2X7R were retrieved from the Web of Science Core Collection database. Quantitative analysis and visualization tools were Microsoft Excel, VOSviewer, and CiteSpace software. The analysis content included publication trends, literature co-citation, and keywords. 3282 records were included in total, with the majority of papers published within the last 10 years. Based on literature co-citation and keyword analysis, neuroinflammation, neuropathic pain, gastrointestinal diseases, tumor microenvironment, rheumatoid arthritis, age-related macular degeneration, and P2X7R antagonists were considered to be the hotspots and frontiers of P2X7R research. Researchers will get a more intuitive understanding of the status and trends of P2X7R research from this study.
多年来,对P2X7受体(P2X7R)的研究一直在进行。对P2X7R的科学产出和现状进行全面、系统和客观的评估,将有助于指导未来的研究方向。本研究旨在呈现2002年至2023年P2X7R研究的现状和趋势。与P2X7R相关的出版物从Web of Science核心合集数据库中检索。定量分析和可视化工具为Microsoft Excel、VOSviewer和CiteSpace软件。分析内容包括发表趋势、文献共被引和关键词。总共纳入3282条记录,其中大部分论文是在过去10年内发表的。基于文献共被引和关键词分析,神经炎症、神经性疼痛、胃肠道疾病、肿瘤微环境、类风湿性关节炎、年龄相关性黄斑变性和P2X7R拮抗剂被认为是P2X7R研究的热点和前沿。通过本研究,研究人员将对P2X7R研究的现状和趋势有更直观的了解。